Literature DB >> 15864779

Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens.

Ruobing Wang1, Myriam Arevalo-Herrera, Malcolm J Gardner, Anilza Bonelo, Jane M Carlton, Andres Gomez, Omaira Vera, Liliana Soto, Juana Vergara, Shelby L Bidwell, Alexander Domingo, Claire M Fraser, Socrates Herrera.   

Abstract

Duffy antigen is the receptor used by Plasmodium vivax to invade erythrocytes. Consequently, individuals lacking Duffy antigen [Fy(-)] do not develop blood-stage infections. We hypothesized that naturally exposed Fy(-) humans may develop immune responses mainly to pre-erythrocytic stages and could be used to study acquired immunity to P. vivax and to identify liver-stage antigens. We report here that antibody and IFN-gamma responses to known sporozoite antigens were significantly induced by natural exposure in Fy(-) humans, whereas responses to blood-stage antigens were significantly induced in Fy(+) humans. IFN-gamma responses to sporozoite antigens were lower in Fy(+) than in Fy(-) humans, indicating that in Fy(+) humans blood-stage infections may have suppressed T cell responses to pre-erythrocytic stages. We evaluated the immune responses to 18 novel P. vivax homologs of P. falciparum sporozoite proteins identified from the P. vivax genome sequence. Eight proteins recalled IFN-gamma responses in P. vivax-exposed but not in unexposed individuals. Of these, 3 antigens elicited IFN-gamma responses in Fy(-) but not in Fy(+) individuals. These results suggest that differential immune responses observed in naturally exposed Fy(-) and Fy(+) individuals can be exploited to identify P. vivax stage-specific antigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864779     DOI: 10.1002/eji.200425807

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

2.  Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses.

Authors:  Douglas M Molina; Olivia C Finney; Myriam Arevalo-Herrera; Socrates Herrera; Philip L Felgner; Malcolm J Gardner; Xiaowu Liang; Ruobing Wang
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

3.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

4.  A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations.

Authors:  Sean C Murphy; Arnold Kas; Brad C Stone; Michael J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

5.  Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

Authors:  Amanda Maestre; Carlos Muskus; Victoria Duque; Olga Agudelo; Pu Liu; Akihide Takagi; Francis B Ntumngia; John H Adams; Kim Lee Sim; Stephen L Hoffman; Giampietro Corradin; Ivan D Velez; Ruobing Wang
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

6.  Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii.

Authors:  K A Wong; A Zhou; A Rodriguez
Journal:  Parasite Immunol       Date:  2008-09       Impact factor: 2.280

Review 7.  Plasmodium cellular effector mechanisms and the hepatic microenvironment.

Authors:  Ute Frevert; Urszula Krzych
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

8.  Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.

Authors:  Lin Chen; Gladys J Keitany; Xiaohong Peng; Claire Gibson; Isaac Mohar; Marissa Vignali; Ian N Crispe; Fusheng Huang; Ruobing Wang
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.

Authors:  Carmen Fernandez-Becerra; Sergi Sanz; Marina Brucet; Danielle I Stanisic; Fabiana P Alves; Erney P Camargo; Pedro L Alonso; Ivo Mueller; Hernando A del Portillo
Journal:  Malar J       Date:  2010-01-21       Impact factor: 2.979

10.  Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens.

Authors:  Brad C Stone; Arnold Kas; Zachary P Billman; Deborah H Fuller; James T Fuller; Jay Shendure; Sean C Murphy
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.